Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 216 participants.
Also called NCT02059785
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 216 participants
- Registry
-
NCT02059785
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Suspended
Technical summary
Registry record NCT02059785. Randomized; triple masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Pinocembrin for Injection
- Lead sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct02059785- Content hash
d8ba62947830081551c34832fe206a50257fbf72fd4c22e680dcecbf27c479b8